Severe Combined Immunodeficiency

Severe Combined Immunodeficiency (SCID) is a rare group of birth defects. It affects the immune system, making it very hard for the body to fight off infections. People with SCID often get sick very easily and need frequent medical care.

Condition

What people with Severe Combined Immunodeficiency report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for Severe Combined Immunodeficiency?

NameHow it went

About Severe Combined Immunodeficiency

What It Is

Severe combined immunodeficiency (SCID) is a group of rare inherited conditions in which a baby is born without an immune system that can protect them. The central problem is T cells, the white blood cells that direct the body's response to germs. In SCID they are missing or do not work, and because T cells also help other immune cells make antibodies, both main arms of the immune system fail. That combined failure gives the condition its name. Babies with SCID usually look healthy at birth, partly because antibodies passed from the mother protect them for the first months. Without treatment, they develop repeated, severe infections, including from germs that rarely harm other children, along with persistent thrush (a fungal infection of the mouth), chronic diarrhea and poor growth. Untreated SCID is usually fatal within the first year or two of life. With early diagnosis and treatment, most babies now survive.

Causes & Risk Factors

SCID is caused by changes (variants) in one of more than 20 genes that immune cells need in order to develop. It is not caused by anything a parent did during pregnancy, and it is not caught from someone else. The most common form, X-linked SCID, comes from a variant in a gene on the X chromosome. Because boys have only one X chromosome, a single altered copy is enough to cause the condition, so this form almost always affects boys. Most other forms are recessive: a child is affected only after inheriting an altered copy from each parent, and parents who carry one copy are healthy. One recessive form, ADA-SCID, is caused by a missing enzyme called adenosine deaminase (ADA); without it, toxic by-products build up and kill developing immune cells, and can also affect the lungs, liver, kidneys, bones and brain. Across all types, SCID affects about 1 in 58,000 babies in the United States.

How It's Diagnosed

In the United States, most babies with SCID are now found through the routine heel-prick newborn screen before they get sick. The screen measures TRECs (T-cell receptor excision circles), small pieces of DNA left behind when new T cells are made. A very low or absent TREC level means the baby is making few new T cells. It is a screening result, not a diagnosis: other conditions that lower T cells, such as DiGeorge syndrome (a chromosome condition that can affect the thymus, where T cells mature), can also cause a positive screen. A positive screen needs immediate follow-up, with confirmatory testing ideally within two weeks. The key test is flow cytometry, a blood test that counts T cells, B cells and natural killer (NK) cells. In typical SCID, the T-cell count is below 50 cells per microliter, compared with roughly 2,500 or more in a healthy infant, and the few T cells present barely respond when stimulated in the lab. Antibody levels and genetic testing help identify the exact type, which guides treatment and family planning, although a gene result is not required to make the diagnosis. Screening does not catch every case. Leaky SCID, in which some T cells are made but work poorly, and a late-onset form of ADA-SCID can be missed. Omenn syndrome, a form of leaky SCID, can cause a widespread red, peeling rash, swollen lymph nodes and an enlarged liver and spleen; these signs in an infant call for an immune evaluation even if the newborn screen was normal.

Treatment Options

The goal of treatment is to give the child a working immune system, and timing matters more than almost anything else. Until that happens, care focuses on preventing infection. Protection starts as soon as SCID is suspected. The baby is kept in protective isolation, with no visitors, strict handwashing and no contact with anyone who is sick, especially other young children. Live vaccines, including the rotavirus vaccine routinely given in infancy, can cause life-threatening infection in these babies and must not be given. Family members should keep up with their own vaccines, such as the yearly flu shot, though the care team may ask siblings to avoid certain live vaccines. Breastfeeding is paused until the mother is tested for CMV (cytomegalovirus, a common virus that can be dangerous for these babies), and replaced with formula if she carries it. Any blood transfusion must be irradiated, filtered and CMV-negative. Babies also receive immunoglobulin (antibody) infusions and preventive medicines against pneumonia and fungal and viral infections. The standard cure is a stem cell transplant, often called a bone marrow transplant, which uses donor bone marrow or umbilical cord blood to rebuild the immune system. A matched brother or sister is the preferred donor; unrelated or partly matched donors are used when no sibling matches. Outcomes depend heavily on timing: about 94% of infants transplanted before three and a half months of age survive five years, compared with about half of older infants who have an active infection at the time of transplant. T cells usually recover well, but some children still need antibody infusions afterward because their B cells do not fully recover. For ADA-SCID, enzyme replacement with elapegademase (Revcovi), given by injection into a muscle, supplies the missing enzyme and restores some immune function while a transplant or gene therapy is planned. It is not a cure, and its effect can fade over time. Gene therapy, which adds a working copy of the gene to the child's own stem cells, has worked for ADA-SCID and X-linked SCID. In the United States it is mainly available through research studies. It avoids the need for a donor but carries its own risks. Early gene therapy with older vector designs (the part that carries the gene into cells) caused leukemia in some children, mostly in the first X-linked SCID trials. Newer vector designs aim to lower this risk, which is still being studied in long-term follow-up.

What to Expect

The first months after diagnosis are intense. Families typically live under strict infection precautions while working closely with a specialized immunology and transplant center, which may be far from home. This period is recognized as especially hard on parents, and social work and family support are part of good care. After a transplant or gene therapy, the new immune system takes time to rebuild, and the care team decides when precautions can ease. Follow-up continues for years, often into adulthood, because survivors can have late effects: chronic graft-versus-host disease (donor immune cells attacking the child's tissues, which can affect the skin, gut, joints or lungs and lasts for years in about 15% of children), an ongoing need for antibody infusions, persistent wart virus (HPV) infections, and growth or nutrition problems. Which of these appear depends on the genetic type, any infections before treatment and whether chemotherapy was used to prepare for the transplant.

When to Seek Help

If you are contacted about a positive SCID newborn screen, respond right away and arrange the confirmatory testing promptly; the specialist team will explain what precautions to take in the meantime. For a baby with suspected or confirmed SCID, call the immunology team right away about a fever, cough or breathing changes, diarrhea or a new rash, because infection before the immune system is rebuilt is the biggest threat to a good outcome. Ask for an immune evaluation for any infant or young child with repeated or unusually severe infections, thrush that keeps coming back, ongoing diarrhea or poor weight gain, even if the newborn screen was normal. Families with a history of SCID or another inherited immune disorder can ask about genetic counseling before planning a pregnancy.

Questions to Ask Your Doctor

  1. 1.What type of SCID does my child have, and how does that change the treatment plan?
  2. 2.Is a matched donor available, and how soon could a transplant or other treatment happen?
  3. 3.Which precautions should our household follow until treatment works, and who do we call if our baby gets a fever?
  4. 4.What long-term follow-up will my child need after treatment?
  5. 5.What is the chance that a future child could have SCID, and what testing is available?

Last reviewed • Oct 2026

Educational content, not medical advice.